BillionToOne (BLLN) Stock Forecast: StockMap's 2-Week Call

BLLN stock forecast: StockMap's model makes no two-week call on BillionToOne after the Nov 19 close: its evidence is split, 6 reasons for and 9 against. Right in 1 of 5 two-week windows on BLLN since Aug 21; by chance, a call on the same dates was right 66% of the time.

BillionToOne last closed at $90.20, -1.46% on the session.

Against the IVW growth benchmark the position is +0.87% over the forecast window.

BillionToOne's market cap is $4.31B as of November 19, 2026.

No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 18 (too close to call).

Where BLLN sits: sized by market cap, coloured by the day's move.

The read is built from 15 underlying insights — 6 bullish and 9 bearish.

Agreement across those insights is 40%.

31 daily calls for BLLN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks BillionToOne in the 4th percentile on valuation and the 58th percentile on return on equity, where 100 is best.

BillionToOne is classified under Health Care / Health Care Providers & Services.

StockMap tracks BillionToOne as the 31st largest of the 87 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 52 Neutral, 18 Moderate Underperform, 12 Moderate Outperform and 5 Strong Underperform.

On that composite BillionToOne ranks 14th of 87 in the group, against a group median of -0.06.

Other Health Care stocks

Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 19, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.

BillionToOne (BLLN) — StockMap 2-week forecast & tracked accuracy